These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27707569)

  • 1. Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol.
    Richards JR; Lange RA; Arnold TC; Horowitz BZ
    Am J Emerg Med; 2017 Mar; 35(3):519.e1-519.e4. PubMed ID: 27707569
    [No Abstract]   [Full Text] [Related]  

  • 2. Labetalol and cardiovascular consequences of cocaine use.
    Richards JR; Lange RA
    Trends Cardiovasc Med; 2016 Feb; 26(2):202-3. PubMed ID: 26116092
    [No Abstract]   [Full Text] [Related]  

  • 3. β-Blockers, Cocaine, and the Unopposed α-Stimulation Phenomenon.
    Richards JR; Hollander JE; Ramoska EA; Fareed FN; Sand IC; Izquierdo Gómez MM; Lange RA
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):239-249. PubMed ID: 28399647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methamphetamine and the expanding complications of amphetamines.
    Albertson TE; Derlet RW; Van Hoozen BE
    West J Med; 1999 Apr; 170(4):214-9. PubMed ID: 10344175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes.
    Honderick T; Williams D; Seaberg D; Wears R
    Am J Emerg Med; 2003 Jan; 21(1):39-42. PubMed ID: 12563578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular complications associated with cocaine use.
    Velasquez EM; Anand RC; Newman WP; Richard SS; Glancy DL
    J La State Med Soc; 2004; 156(6):302-10; quiz 311. PubMed ID: 15688670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cocaine cardiovascular toxicity: a systematic review.
    Richards JR; Garber D; Laurin EG; Albertson TE; Derlet RW; Amsterdam EA; Olson KR; Ramoska EA; Lange RA
    Clin Toxicol (Phila); 2016 Jun; 54(5):345-64. PubMed ID: 26919414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine and acute vascular diseases.
    De Giorgi A; Fabbian F; Pala M; Bonetti F; Babini I; Bagnaresi I; Manfredini F; Portaluppi F; Mikhailidis DP; Manfredini R
    Curr Drug Abuse Rev; 2012 Jun; 5(2):129-34. PubMed ID: 22455504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Toxicity from Topical Cocaine for Epistaxis: Treatment with Labetalol.
    Richards JR; Laurin EG; Tabish N; Lange RA
    J Emerg Med; 2017 Mar; 52(3):311-313. PubMed ID: 27693072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of patients with methamphetamine- and cocaine-related chest pain in a chest pain observation unit.
    Diercks DB; Kirk JD; Turnipseed SD; Amsterdam EA
    Crit Pathw Cardiol; 2007 Dec; 6(4):161-4. PubMed ID: 18091405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying patients with cocaine-related chest pain at true risk for beta-blocker toxicity.
    Canning J; Brooks DE; Gerkin RD
    Arch Intern Med; 2010 Nov; 170(20):1859; author reply 1860. PubMed ID: 21059983
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical use of lorazepam in postoperative intensive care.
    Camu F
    Acta Anaesthesiol Belg; 1978; 29(2):191-200. PubMed ID: 32731
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia.
    Jaehne EJ; Salem A; Irvine RJ
    Psychopharmacology (Berl); 2007 Sep; 194(1):41-52. PubMed ID: 17530474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral effects of ketamine and toxic interactions with psychostimulants.
    Hayase T; Yamamoto Y; Yamamoto K
    BMC Neurosci; 2006 Mar; 7():25. PubMed ID: 16542420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorazepam-induced diplopia.
    Lucca JM; Ramesh M; Parthasarathi G; Ram D
    Indian J Pharmacol; 2014; 46(2):228-9. PubMed ID: 24741200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversial therapeutics: the β-adrenergic antagonist and cocaine-associated cardiovascular complications dilemma.
    Schurr JW; Gitman B; Belchikov Y
    Pharmacotherapy; 2014 Dec; 34(12):1269-81. PubMed ID: 25224512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the clinical pharmacology of methamphetamine.
    Cruickshank CC; Dyer KR
    Addiction; 2009 Jul; 104(7):1085-99. PubMed ID: 19426289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine and cardiovascular complications.
    Bhargava S; Arora RR
    Am J Ther; 2011 Jul; 18(4):e95-e100. PubMed ID: 21150772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of cardiovascular response to methamphetamine administration in methamphetamine-dependent individuals.
    Fleury G; De La Garza R; Mahoney JJ; Evans SE; Newton TF
    Am J Addict; 2008; 17(2):103-10. PubMed ID: 18393052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular complication of cocaine abuse].
    Goleń D; Kuśmierczyk Droszcz B; Demkow M; Bilińska ZT
    Kardiol Pol; 2012; 70(5):517-21. PubMed ID: 22623250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.